MAP1LC3B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.976800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.317800E-01
Normal-vs-Stage2
8.070800E-01
Normal-vs-Stage3
6.905400E-01
Normal-vs-Stage4
2.428600E-01
Stage1-vs-Stage2
8.416000E-01
Stage1-vs-Stage3
6.057000E-01
Stage1-vs-Stage4
3.486400E-01
Stage2-vs-Stage3
3.989000E-01
Stage2-vs-Stage4
2.410100E-02
Stage3-vs-Stage4
2.142400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.123200E-01
Normal-vs-AfricanAmerican
6.690000E-01
Normal-vs-Asian
7.614800E-01
Caucasian-vs-AfricanAmerican
6.873400E-01
Caucasian-vs-Asian
3.281400E-01
AfricanAmerican-vs-Asian
3.214600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.957000E-01
Normal-vs-Female
7.998000E-01
Male-vs-Female
8.309400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.367600E-01
Normal-vs-Age(41-60Yrs)
3.276400E-01
Normal-vs-Age(61-80Yrs)
9.938800E-01
Normal-vs-Age(81-100Yrs)
9.368600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.745600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.043200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.979200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.743200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.901400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.277400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.732800E-01
Normal-vs-Daily Drinker
8.214400E-01
Normal-vs-Weekly Drinker
9.896800E-01
Normal-vs-Occasional Drinker
5.197800E-01
Normal-vs-Social Drinker
8.728400E-01
Non Drinker-vs-Daily Drinker
9.345600E-01
Non Drinker-vs-Weekly Drinker
5.843400E-01
Non Drinker-vs-Occasional Drinker
4.832000E-02
Non Drinker-vs-Social Drinker
7.983600E-01
Daily Drinker-vs-Weekly Drinker
6.695000E-01
Daily Drinker-vs-Occasional Drinker
8.863500E-02
Daily Drinker-vs-Social Drinker
8.725000E-01
Weekly Drinker-vs-Occasional Drinker
2.524800E-01
Weekly Drinker-vs-Social Drinker
7.827000E-01
Occasional Drinker-vs-Social Drinker
1.406800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.787000E-01
Normal-vs-Grade 2
4.932500E-02
Normal-vs-Grade 3
1.332820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.046030E-02
Grade 1-vs-Grade 3
1.380980E-01
Grade 1-vs-Grade 4
2.787000E-01
Grade 2-vs-Grade 3
3.790400E-01
Grade 2-vs-Grade 4
4.932500E-02
Grade 3-vs-Grade 4
1.332820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.578400E-01
Normal-vs-NonDiabetic
8.290600E-01
Diabetic-vs-NonDiabetic
6.403200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.208600E-01
Normal-vs-NoPancreatitis
8.559200E-01
Pancreatitis-vs-NoPancreatitis
9.540600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.111400E-01
Normal-vs-N1
7.945800E-01
N0-vs-N1
9.221200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.092800E-01
Normal-vs-TP53-NonMutant
7.164200E-01
TP53-Mutant-vs-TP53-NonMutant
1.423850E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
